Newsfeeds - Spark Newswire

1 minute read

Uncategorized

Belgium Stops JNJ COVID-19 Vaccine For Under 41 Years After One Death: Reuters

Today, 8:24 AM

Belgium is suspending vaccinations with Johnson & Johnson's (NYSE: JNJ) COVID-19 vaccine for people under the age of 41 following the death of a woman from severe side effects after receiving the shot.

JNJ

1 minute read

Uncategorized

EU Drug Regulator Says Has Asked Johnson & Johnson To Carry Out Additional Studies To Assess Possible Link Between Vaccine And Rare Clotting

By Benzinga Newsdesk

Today, 8:24 AM

-Reuters

JNJ

1 minute read

Uncategorized

Moderna Sees Single-Dose COVID-19 Vaccine Launch In India In 2022

By Vandana Singh

Today, 8:24 AM

Moderna Inc (NASDAQ: MRNA) expects to launch a single-dose COVID-19 vaccine in India in 2022 and is in talks…

BNTX

2 minute read

Uncategorized

Microsoft, Apple, Disney Lead The Dow Jones Higher Monday

By Henry Khederian

Today, 8:24 AM

U.S. indices were trading higher throughout Monday's session amid a rebound in tech names and strength in reopening plays. Here's how each of the major indices performed for the trading day:

AAPL

1 minute read

Uncategorized

Janssen’s Multiple Sclerosis Treatment Scores European Approval

By Vandana Singh

Today, 8:24 AM

The European Commission has approved Janssen’s, a unit of Johnson & Johnson (NYSE: JNJ) Ponvory (ponesimod), to treat adult patients with…

JNJ

3 minute read

Uncategorized

The Power and Precision of BioSig’s PURE EP™ System in the Electrophysiology (EP) Market

By Dinah Berkeley

Today, 8:24 AM

Arrhythmia, a condition that causes the heart to beat with an irregular or abnormal rhythm, is the fourth leading disease in the United States. Untreated or undiagnosed, arrhythmias can increase the risk of severe health complications—including stroke or even death.

ABT

1 minute read

Uncategorized

Janssen Announces European Commission Approval Of PONVORYTM

By Bill Haddad

Today, 8:24 AM

https://www.janssen.com/european-commission-approves-ponvory-v-ponesimod-once-daily-oral-therapy-treatment-adults

JNJ

1 minute read

Uncategorized

‘Halftime Report’ Traders Share Their Thoughts On Target, Home Depot And More

By Craig Jones

Today, 8:24 AM

On CNBC's "Fast Money Halftime Report," Bryn Talkington answered a question from a viewer who wanted to know where to invest his $3,500.

AAPL

1 minute read

Uncategorized

JNJ’s Rybrevant Scores FDA Approval In Lung Cancer Patients With EGFR Exon 20 Mutation

By Vandana Singh

Today, 8:24 AM

The FDA has approved Janssen Pharmaceutical Companies‘ a unit of Johnson & Johnson (NYSE: JNJ) Rybrevant (amivantamab-vmjw) for a subset of non-small…

JNJ

1 minute read

Uncategorized

Genmab – Janssen’s Darzalex Wins Positive Opinion In Europe For Two New Indications

By Vandana Singh

Today, 8:24 AM

Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion and recommended granting…

GMAB